Publications: Knight, Daniel

2022

Hain‐Saunders, N.M.R., Knight, D.R.ORCID: 0000-0002-9480-4733, Bruce, M.ORCID: 0000-0003-3176-2094 and Riley, T.V. (2022) Clostridioides difficile infection and One Health: An equine perspective. Environmental Microbiology, 24 (3). pp. 985-997.

Pitcher, N.P., Harjani, J.R., Zhao, Y., Jin, J., Knight, D.R.ORCID: 0000-0002-9480-4733, Li, L., Putsathit, P., Riley, T.V., Carter, G.P. and Baell, J.B. (2022) Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract. ACS Omega, 7 (8). pp. 6737-6759.

Shivaperumal, N., Knight, D.R.ORCID: 0000-0002-9480-4733, Imwattana, K., Androga, G.O., Chang, B.J. and Riley, T.V. (2022) Esculin hydrolysis negative and TcdA ‐only producing strains of clostridium (Clostridiodes) difficile from the environment in Western Australia. Journal of Applied Microbiology, 133 (3). pp. 1183-1196.

Imwattana, K., Putsathit, P., Collins, D.A., Leepattarakit, T., Kiratisin, P., Riley, T.V. and Knight, D.R.ORCID: 0000-0002-9480-4733 (2022) Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017. Microbial Genomics, 8 (3). Art. 000792.

2021

O'Grady, K., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2021) Antimicrobial resistance in Clostridioides difficile. European Journal of Clinical Microbiology & Infectious Diseases .

Putsathit, P., Hong, S., George, N., Hemphill, C., Huntington, P.G., Korman, T.M., Kotsanas, D., Lahra, M., McDougall, R., McGlinchey, A., Moore, C.V., Nimmo, G.R., Prendergast, L., Robson, J., Waring, L., Wehrhahn, M.C., Weldhagen, G.F., Wilson, R.M., Riley, T.V. and Knight, D.R.ORCID: 0000-0002-9480-4733 (2021) Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–18. Journal of Antimicrobial Chemotherapy, 76 (7). pp. 1815-1821.

Imwattana, K., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2021) Can sequencing improve the diagnosis and management of Clostridioides difficile infection? Expert Review of Molecular Diagnostics . pp. 1-3.

Mahadari, M.K., Jennepalli, S., Tague, A.J., Putsathit, P., Hutton, M.L., Hammer, K.A., Knight, D.R.ORCID: 0000-0002-9480-4733, Riley, T.V., Lyras, D., Keller, P.A. and Pyne, S.G. (2021) Cationic peptidomimetic amphiphiles having a N-aryl- or N-naphthyl-1,2,3-triazole core structure targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation, and an in vivo C. difficile infection model. Antibiotics, 10 (8). Article 913.

O'Grady, K., Riley, T.V., Knight, D.R.ORCID: 0000-0002-9480-4733 and Rasko, D. (2021) Complete genome assemblies of three highly prevalent, toxigenic Clostridioides difficile strains causing health care-associated infections in Australia. Microbiology Resource Announcements, 10 (31). pp. 1-3.

Knight, D.R.ORCID: 0000-0002-9480-4733, Imwattana, K., Kullin, B., Guerrero-Araya, E., Paredes-Sabja, D., Didelot, X., Dingle, K.E., Eyre, D.W., Rodriguez, C. and Riley, T.V. (2021) Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy. eLife, 10 . Art. e64325.

Imwattana, K., Putsathit, P., Knight, D.R.ORCID: 0000-0002-9480-4733, Kiratisin, P. and Riley, T.V. (2021) Molecular characterization of, and antimicrobial resistance in, clostridioides difficile from Thailand, 2017–2018. Microbial Drug Resistance . ahead-of-print.

Lim, S‐C, Collins, D.A., Imwattana, K., Knight, D.R.ORCID: 0000-0002-9480-4733, Perumalsamy, S., Hain‐Saunders, N.M.R., Putsathit, P., Speers, D. and Riley, T.V. (2021) Whole‐genome sequencing links Clostridium ( Clostridioides ) difficile in a single hospital to diverse environmental sources in the community. Journal of Applied Microbiology . Early View.

Imwattana, K., Rodriguez, C., Riley, T.V. and Knight, D.R.ORCID: 0000-0002-9480-4733 (2021) A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile. Microbial Genomics, 7 (11). Art. 000696.

2020

Imwattana, K., Knight, D.R.ORCID: 0000-0002-9480-4733, Kullin, B., Collins, D.A., Putsathit, P., Kiratisin, P. and Riley, T.V. (2020) Antimicrobial resistance in Clostridium difficile ribotype 017. Expert Review of Anti-infective Therapy, 18 (1). pp. 17-25.

Lim, S‐C, Knight, D.R.ORCID: 0000-0002-9480-4733, Moono, P., Foster, N.F. and Riley, T.V. (2020) Clostridium difficile in soil conditioners, mulches and garden mixes with evidence of a clonal relationship with historical food and clinical isolates. Environmental Microbiology Reports . Early View.

Knight, D.ORCID: 0000-0002-9480-4733 (2020) Genomic and Evolutionary Insights into C. difficile, the Quintessential One Health Pathogen. In: 15th Biennial Congress of the Anaerobe Society of the Americas (VIRTUAL), 23 - 24 July 2020, Seattle, WA.

Imwattana, K., Kiratisin, P., Riley, T.V. and Knight, D.R.ORCID: 0000-0002-9480-4733 (2020) Genomic basis of antimicrobial resistance in non-toxigenic Clostridium difficile in Southeast Asia. Anaerobe, 66 . Art. 102290.

Perumalsamy, S., Hong, S., Knight, D.ORCID: 0000-0002-9480-4733 and Riley, T. (2020) Laboratory surveillance of paediatric Clostridium difficile infections in healthcare and community settings in Australia, from 2013 to at present. International Journal of Infectious Diseases, 101 . p. 438.

Hong, S., Putsathit, P., George, N., Hemphill, C., Huntington, P.G., Korman, T.M., Kotsanas, D., Lahra, M., McDougall, R., Moore, C.V., Nimmo, G.R., Prendergast, L., Robson, J., Waring, L., Wehrhahn, M.C., Weldhagen, G.F., Wilson, R.M., Riley, T.V., Knight, D.R.ORCID: 0000-0002-9480-4733 and Diekema, D.J. (2020) Laboratory-based surveillance of Clostridium difficile Infection in Australian health care and community settings, 2013 to 2018. Journal of Clinical Microbiology, 58 (11). e01552-20.

Lim, S-C, Riley, T.V. and Knight, D.R.ORCID: 0000-0002-9480-4733 (2020) One Health: The global challenge of Clostridium difficile infection. Microbiology Australia, 41 (1). pp. 23-27.

2019

Tague, A.J., Putsathit, P., Hutton, M.L., Hammer, K.A., Wales, S.M., Knight, D.R.ORCID: 0000-0002-9480-4733, Riley, T.V., Lyras, D., Keller, P.A. and Pyne, S.G. (2019) Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model. European Journal of Medicinal Chemistry, 170 . pp. 203-224.

Tague, A.J., Putsathit, P., Hammer, K.A., Wales, S.M., Knight, D.R.ORCID: 0000-0002-9480-4733, Riley, T.V., Keller, P.A. and Pyne, S.G. (2019) Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: Synthesis, antibacterial evaluation and preliminary mechanism of action studies. European Journal of Medicinal Chemistry, 168 . pp. 386-404.

Lim, S.C., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2019) Clostridium difficile and One Health. Clinical Microbiology and Infection, 26 (7). P857-863.

Knight, D.R.ORCID: 0000-0002-9480-4733 (2019) Clostridium difficile infection: New insights in to AMR and zoonotic transmission. In: Symposium. Pathogen Discovery: From Genomics to Disease Recognition and Response, 2 - 3 May 2019, The University Club of Western Australia, Crawley.

Imwattana, K., Knight, D.R.ORCID: 0000-0002-9480-4733, Kullin, B., Collins, D.A., Putsathit, P., Kiratisin, P. and Riley, T.V. (2019) Clostridium difficile ribotype 017 – characterization, evolution and epidemiology of the dominant strain in Asia. Emerging Microbes & Infections, 8 (1). pp. 796-807.

Knight, D.R.ORCID: 0000-0002-9480-4733, Kullin, B., Androga, G.O., Barbut, F., Eckert, C., Johnson, S., Spigaglia, P., Tateda, K., Tsai, P-J, Riley, T.V. and Onderdonk, A.B. (2019) Evolutionary and genomic insights into Clostridioides difficile sequence Type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one health importance. mBio, 10 (2). e00446-19.

Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2019) Genomic delineation of zoonotic origins of clostridium difficile. Frontiers in Public Health, 7 . Article 164.

Androga, G.O., Knight, D.R.ORCID: 0000-0002-9480-4733, Hutton, M.L., Mileto, S.J., James, M.L., Evans, C., Lyras, D., Chang, B.J., Foster, N.F. and Riley, T.V. (2019) In silico, in vitro and in vivo analysis of putative virulence factors identified in large clostridial toxin-negative, binary toxin producing C. difficile strains. Anaerobe, 60 (Supp. 1). Art.102083.

Putsathit, P., Neela, V.K., Joseph, N.M.S., Ooi, P.T., Ngamwongsatit, B., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2019) Molecular epidemiology of Clostridium difficile isolated from piglets. Veterinary Microbiology, 237 . Article 108408.

Knight, D.ORCID: 0000-0002-9480-4733 and Doherty, P. (2019) New evidence for a zoonotic potential of Clostridium difficile. In: 29th Annual Congress of the European Society of Clinical Microbiology and Infectious Diseases, 13 - 16 April 2019, Amsterdam, the Netherlands.

Knight, D.ORCID: 0000-0002-9480-4733 (2019) One Health: the optimal paradigm for studying evolution and transmission in Clostridium difficile. In: Breakfast Seminar Series. Infectious Diseases, November 2019, Pathwest Laboratory Medicine. The University of Western Australia.

Hong, S., Knight, D.R.ORCID: 0000-0002-9480-4733, Chang, B., Carman, R.J. and Riley, T.V. (2019) Phenotypic characterisation of Clostridium difficile PCR ribotype 251, an emerging multi-locus sequence type clade 2 strain in Australia. Anaerobe, 60 (Supp. 1). Art.102066.

Azimirad, M., Gholami, F., Yadegar, A., Knight, D.R.ORCID: 0000-0002-9480-4733, Shamloei, S., Aghdaei, H.A. and Zali, M.R. (2019) Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran. Scientific Reports, 9 . Article number 7792.

Hong, S., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2019) The impact of antimicrobial resistance on induction, transmission and treatment of Clostridium difficile infection. Microbiology Australia, 40 . pp. 77-81.

2018

Knight, D.ORCID: 0000-0002-9480-4733 (2018) AMR in zoonotic lineages of C. difficile. In: 19th Annual Scientific Meeting Australian Society for Antimicrobials, 22 - 24 February 2018, Brisbane Convention and Exhibition Centre, Australia

Androga, G.O., Knight, D.R.ORCID: 0000-0002-9480-4733, Lim, S.C., Foster, N.F. and Riley, T.V. (2018) Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes. Anaerobe, 54 . pp. 55-60.

Lim, S-C, Androga, G.O., Knight, D.R.ORCID: 0000-0002-9480-4733, Moono, P., Foster, N.F. and Riley, T.V. (2018) Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia. International Journal of Antimicrobial Agents, 52 (3). pp. 411-415.

Knight, D.ORCID: 0000-0002-9480-4733 (2018) Clostridium difficile Infection in Australia: not so nosocomial anymore. In: 46th Annual Scientific Meeting Australian Society Microbiology (ASM), 1 - 4 July 2018, Brisbane, Australia.

Roshan, N., Riley, T.V., Knight, D.R.ORCID: 0000-0002-9480-4733 and Hammer, K.A. (2018) Effect of natural products on the production and activity of Clostridium difficile toxins in vitro. Scientific Reports, 8 . Article 15735.

Amy, J., Bulach, D., Knight, D.ORCID: 0000-0002-9480-4733, Riley, T., Johanesen, P. and Lyras, D. (2018) Identification of large cryptic plasmids in Clostridioides (Clostridium) difficile. Plasmid, 96-97 . pp. 25-38.

Roshan, N., Riley, T.V., Knight, D.R.ORCID: 0000-0002-9480-4733, Steer, J.H. and Hammer, K.A. (2018) Natural products show diverse mechanisms of action against Clostridium difficile. Journal of Applied Microbiology, 126 (2). pp. 468-479.

Knight, D.ORCID: 0000-0002-9480-4733 (2018) One Health: the optimal paradigm for studying evolution and transmission in C. difficile. In: 6th International Clostridium Difficile Symposium (ICDS), 12 - 14 September 2018, Bled, Slovenia.

Man, N.Y.T., Knight, D.R.ORCID: 0000-0002-9480-4733, Stewart, S.G., McKinley, A.J., Riley, T.V. and Hammer, K.A. (2018) Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound. Scientific Reports, 8 . Article number: 6912.

Knight, D.ORCID: 0000-0002-9480-4733 (2018) Using microbial genomics to provide novel insights into Clostridium difficile Infection. In: COMBINE Network Seminar Event. The Australian Bioinformatics And Computational Biology Society (ABACBS)/Perkins Institute for Medical Research/QEII Medical Centre, April 2018, Perth, Western Australia.

Wehrhahn, M.C., Keighley, C., Kurtovic, J., Knight, D.R.ORCID: 0000-0002-9480-4733, Hong, S., Hutton, M.L., Lyras, D., Wang, Q., Leong, R., Borody, T., Edye, M. and Riley, T.V. (2018) A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain. Anaerobe, 55 . pp. 117-123.

2017

Putsathit, P., Maneerattanaporn, M., Piewngam, P., Knight, D.R.ORCID: 0000-0002-9480-4733, Kiratisin, P. and Riley, T.V. (2017) Antimicrobial susceptibility of Clostridium difficile isolated in Thailand. Antimicrobial Resistance & Infection Control, 6 . Article number: 58.

Elliott, B., Androga, G.O., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2017) Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology. Infection, Genetics and Evolution, 49 . pp. 1-11.

Knight, D.ORCID: 0000-0002-9480-4733 (2017) Clostridium difficile ‒ the quintessential One Health pathogen. In: Research and Training Seminar series 2017. The Marshall Centre for Infectious Diseases, August 2017, The University of Western Australia, Perth

Knight, D.R.ORCID: 0000-0002-9480-4733, Squire, M.M., Collins, D.A. and Riley, T.V. (2017) Genome analysis of Clostridium difficile PCR ribotype 014 lineage in Australian pigs and humans reveals a diverse genetic repertoire and signatures of long-range interspecies transmission. Frontiers in Microbiology, 7 . Article 2138.

McGovern, A.M., Androga, G.O., Knight, D.R.ORCID: 0000-0002-9480-4733, Watson, M.W.ORCID: 0000-0002-6438-9225, Elliott, B., Foster, N.F., Chang, B.J. and Riley, T.V. (2017) Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027. PLoS ONE, 12 (11). e0187658.

2016

Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2016) Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin. Journal of Antimicrobial Chemotherapy, 71 (8). pp. 2213-2217.

Moono, P., Foster, N.F., Hampson, D.J.ORCID: 0000-0002-7729-0427, Knight, D.R.ORCID: 0000-0002-9480-4733, Bloomfield, L.E. and Riley, T.V. (2016) Clostridium difficile infection in production animals and Avian species: A review. Foodborne Pathogens and Disease, 13 (12). pp. 647-655.

Knight, D.R.ORCID: 0000-0002-9480-4733, Putsathit, P., Elliott, B. and Riley, T.V. (2016) Contamination of Australian newborn calf carcasses at slaughter with Clostridium difficile. Clinical Microbiology and Infection, 22 (3). 266.e1-266.e7.

Knight, D.ORCID: 0000-0002-9480-4733 (2016) Evolutionary analysis of C. difficile ribotype 014 lineage in Australian pigs and humans. In: The University of Western Australia and PathWest Laboratory Medicine Research Day 2016, October 2016, The University of Western Australia, Perth.

Knight, D.ORCID: 0000-0002-9480-4733 (2016) Genomic signatures of interspecies transmission in the enteric pathogen Clostridium difficile. In: West Coast Microbiome Network (WCMN) Seminar Series 2016, December 2016, Curtin University, WA.

Mc Govern, A.M., Chang, B.J., Pereira, L.A., Riley, T.V., Elliott, B., Foster, N.F. and Knight, D.R.ORCID: 0000-0002-9480-4733 (2016) Human Clostridium difficile infection caused by a livestock-associated PCR ribotype 237 strain in Western Australia. JMM Case Reports, 3 (4).

Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2016) Intrinsic and acquired antimicrobial resistance repertoire of Australian isolates of Clostridium difficile identified on whole genome sequencing. In: 17th Annual Scientific Meeting - Antimicrobials 2016, 25 - 27 February 2016, Melbourne Exhibition Centre, Melbourne

Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2016) Microevolutionary analysis of C. difficile PCR ribotype 014 lineage in Australian porcine and humans reveals signatures of long-range intra- and interspecies transmission. In: 44th Annual Scientific Meeting Australian Society Microbiology (ASM), 3 - 6 July 2016, Perth Convention Centre

Moono, P., Putsathit, P., Knight, D.R.ORCID: 0000-0002-9480-4733, Squire, M.M., Hampson, D.J.ORCID: 0000-0002-7729-0427, Foster, N.F. and Riley, T.V. (2016) Persistence of Clostridium difficile RT 237 infection in a Western Australian piggery. Anaerobe, 37 . pp. 62-66.

Knight, D.R.ORCID: 0000-0002-9480-4733, Androga, G.O., Ballard, S.A., Howden, B.P. and Riley, T.V. (2016) A phenotypically silent vanB2 operon carried on a Tn1549-like element in Clostridium difficile. mSphere, 1 (4). e00177-16.

2015

Squire, M.M., Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2015) Community-acquired Clostridium difficile infection and Australian food animals. Microbiology Australia . pp. 111-113.

Knight, D.R.ORCID: 0000-0002-9480-4733, Elliott, B., Chang, B.J., Perkins, T.T. and Riley, T.V. (2015) Diversity and evolution in the genome of Clostridium difficile. Clinical Microbiology Reviews, 28 (3). pp. 721-741.

Grandgirard, D., Furi, L., Ciusa, M.L., Baldassarri, L., Knight, D.R.ORCID: 0000-0002-9480-4733, Morrissey, I., Largiadèr, C.R., Leib, S.L. and Oggioni, M.R. (2015) Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression. BMC Genomics, 16 . Article number: 345.

Knight, D.R.ORCID: 0000-0002-9480-4733, Squire, M.M. and Riley, T.V. (2015) Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes. Applied and Environmental Microbiology, 81 (1). pp. 119-123.

Oggioni, M.R., Rosado Coelho, J., Furi, L., Knight, D.R.ORCID: 0000-0002-9480-4733, Viti, C., Orefici, G., Martinez, J-L, Teresa Freitas, A., M. Coque, T. and Morrissey, I. (2015) Significant differences characterise the correlation coefficients between biocide and antibiotic susceptibility profiles in Staphylococcus aureus. Current Pharmaceutical Design, 21 (16). pp. 2054-2057.

Knight, D.R.ORCID: 0000-0002-9480-4733, Giglio, S., Huntington, P.G., Korman, T.M., Kotsanas, D., Moore, C.V., Paterson, D.L., Prendergast, L., Huber, C.A., Robson, J., Waring, L., Wehrhahn, M.C., Weldhagen, G.F., Wilson, R.M. and Riley, T.V. (2015) Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013–14. Journal of Antimicrobial Chemotherapy, 70 (11). pp. 2992-2999.

Knight, D.R.ORCID: 0000-0002-9480-4733, Hart, J., Gottardo, N.G, Eyre, D.W, Crook, D.W and Riley, T.V. (2015) Two cases of Clostridium difficile infection in unrelated oncology patients attributable to a single clone of C. difficile PCR ribotype 126. JMM Case Reports, 2 (3).

2014

Hart, J., Putsathit, P., Knight, D.R.ORCID: 0000-0002-9480-4733, Sammels, L., Riley, T.V. and Keil, A. (2014) Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies. European Journal of Clinical Microbiology & Infectious Diseases, 33 (9). pp. 1555-1564.

Morrissey, I., Oggioni, M.R., Knight, D.R.ORCID: 0000-0002-9480-4733, Curiao, T., Coque, T., Kalkanci, A. and Martinez, J.L. (2014) Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PloS ONE, 9 (1). e86669.

Knight, D.R.ORCID: 0000-0002-9480-4733, Squire, M.M. and Riley, T.V. (2014) Laboratory detection of Clostridium difficile in piglets in Australia. Journal of Clinical Microbiology, 52 (11). pp. 3856-3862.

2013

Morrissey, I., Seifert, H., Canton, R., Nordmann, P., Stefani, S., MacGowan, A., Janes, R. and Knight, D.ORCID: 0000-0002-9480-4733 (2013) Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and -haemolytic streptococci collected from western European countries in 2011. Journal of Antimicrobial Chemotherapy, 68 (1). pp. 164-167.

Knight, D.R.ORCID: 0000-0002-9480-4733, Thean, S., Putsathit, P., Fenwick, S. and Riley, T.V. (2013) Cross-sectional study reveals high prevalence of Clostridium difficile Non-PCR ribotype 078 strains in Australian veal calves at slaughter. Applied and Environmental Microbiology, 79 (8). pp. 2630-2635.

Furi, L., Ciusa, M.L., Knight, D.ORCID: 0000-0002-9480-4733, Di Lorenzo, V., Tocci, N., Cirasola, D., Aragones, L., Coelho, J.R., Freitas, A.T., Marchi, E., Moce, L., Visa, P., Northwood, J.B., Viti, C., Borghi, E., Orefici, G., Morrissey, I. and Oggioni, M.R. (2013) Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 57 (8). pp. 3488-3497.

Friedman, N.D., Pollard, J., Stupart, D., Knight, D.R.ORCID: 0000-0002-9480-4733, Khajehnoori, M., Davey, E.K, Parry, L. and Riley, T.V. (2013) Prevalence of Clostridium difficile colonization among healthcare workers. BMC Infectious Diseases, 13 . Article number: 459.

Knight, D.R.ORCID: 0000-0002-9480-4733 and Riley, T.V. (2013) Prevalence of gastrointestinal Clostridium difficile carriage in Australian sheep and lambs. Applied and Environmental Microbiology, 79 (18). pp. 5689-5692.

Coelho, J.R., Carriço, J.A., Knight, D.ORCID: 0000-0002-9480-4733, Martínez, J-L, Morrissey, I., Oggioni, M.R. and Freitas, A.T. (2013) The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus. PloS ONE, 8 (2). e55582.

2012

Knight, D.R.ORCID: 0000-0002-9480-4733, Thean, S., Fenwick, S. and Riley, T.V. (2012) C. difficile from Australian cattle – all will be re(veal)ed! In: 4th International Clostridium difficile Symposium (ICDS), 20 - 22 September 2012, Bled, Slovenia

Knight, D.R.ORCID: 0000-0002-9480-4733 and Squire, M.M. (2012) Prevalence and molecular characterisation of C. difficile in neonatal piglets in Australia. In: 4th Biennial Conference of the Australian Pig Science Association (APSA), November 2012, Melbourne, VIC

Ciusa, M.L., Furi, L., Knight, D.ORCID: 0000-0002-9480-4733, Decorosi, F., Fondi, M., Raggi, C., Coelho, J.R., Aragones, L., Moce, L., Visa, P., Freitas, A.T., Baldassarri, L., Fani, R., Viti, C., Orefici, G., Martinez, J.L., Morrissey, I. and Oggioni, M.R. (2012) A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. International Journal of Antimicrobial Agents, 40 (3). pp. 210-220.

2005

Huber, P.A.J., Birdsey, G.M., Lumb, M.J., Prowse, D.T.R., Perkins, T.J., Knight, D.R.ORCID: 0000-0002-9480-4733 and Danpure, C.J. (2005) Peroxisomal import of human alanine:glyoxylate aminotransferase requires ancillary targeting information remote from its C terminus. Journal of Biological Chemistry, 280 (29). pp. 27111-27120.